Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA,
Target Price
The average target price of HIMS is 20 and suggests 27% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell